Evidence map›Paper›PMID 33308303›Full record

ArticleActa neuropathologica communications2020

Label-free vibrational imaging of different Aβ plaque types in Alzheimer's disease reveals sequential events in plaque development.

Dominik Röhr, Baayla D C Boon, Martin Schuler, Kristin Kremer, Jeroen J M Hoozemans, Femke H Bouwman, Samir F El-Mashtoly, Andreas Nabers, Frederik Großerueschkamp, Annemieke J M Rozemuller and 1 more

Open access · goldAbstract read
In one paragraph

Article in Acta neuropathologica communications, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
4.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 80 citations in OpenAlex.

  1. Regional effects of gantenerumab on neuroimaging biomarkers in the DIAN-TU-001 trial.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Trial
  2. Article
  3. Ex vivo comparison of ACU193 and lecanemab reveals binding differences in mouse brain.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Dominik RöhrDivision of Biospectroscopy, Center for Protein Diagnostics (PRODI), Ruhr University Bochum, Bochum, Germany.ORCID http://orcid.org/0000-0002-9711-0809
Baayla D C BoonDepartment of Pathology, Amsterdam Neuroscience, Amsterdam UMC - Location VUmc, Amsterdam, The Netherlands.ORCID http://orcid.org/0000-0002-4922-3286
Martin SchulerDivision of Biospectroscopy, Center for Protein Diagnostics (PRODI), Ruhr University Bochum, Bochum, Germany.ORCID http://orcid.org/0000-0001-7252-0927
Kristin KremerDivision of Biospectroscopy, Center for Protein Diagnostics (PRODI), Ruhr University Bochum, Bochum, Germany.
Jeroen J M HoozemansDepartment of Pathology, Amsterdam Neuroscience, Amsterdam UMC - Location VUmc, Amsterdam, The Netherlands.ORCID http://orcid.org/0000-0002-2888-8967
Femke H BouwmanDepartment of Neurology, Amsterdam Neuroscience, Alzheimer Center Amsterdam, Amsterdam UMC - Location VUmc, Amsterdam, The Netherlands.ORCID http://orcid.org/0000-0002-0527-2270
Samir F El-MashtolyDivision of Biospectroscopy, Center for Protein Diagnostics (PRODI), Ruhr University Bochum, Bochum, Germany.ORCID http://orcid.org/0000-0001-6087-8817
Andreas NabersDivision of Biospectroscopy, Center for Protein Diagnostics (PRODI), Ruhr University Bochum, Bochum, Germany.ORCID http://orcid.org/0000-0002-0797-3433
Frederik GroßerueschkampDivision of Biospectroscopy, Center for Protein Diagnostics (PRODI), Ruhr University Bochum, Bochum, Germany.ORCID http://orcid.org/0000-0002-0710-6014
Annemieke J M RozemullerDepartment of Pathology, Amsterdam Neuroscience, Amsterdam UMC - Location VUmc, Amsterdam, The Netherlands.ORCID http://orcid.org/0000-0003-2528-4428
Klaus GerwertDivision of Biospectroscopy, Center for Protein Diagnostics (PRODI), Ruhr University Bochum, Bochum, Germany. klaus.gerwert@rub.de.ORCID http://orcid.org/0000-0001-8759-5964
Ruhr University Bochum · DEAmsterdam Neuroscience · NLUniversity Hospitals of the Ruhr-University of Bochum · DE

Funding

NIH HHS 1R01AG061775
6 · The paper itself

Abstract

The neuropathology of Alzheimer's disease (AD) is characterized by hyperphosphorylated tau neurofibrillary tangles (NFTs) and amyloid-beta (Aβ) plaques. Aβ plaques are hypothesized to follow a development sequence starting with diffuse plaques, which evolve into more compact plaques and finally mature into the classic cored plaque type. A better molecular understanding of Aβ pathology is crucial, as the role of Aβ plaques in AD pathogenesis is under debate. Here, we studied the deposition and fibrillation of Aβ in different plaque types with label-free infrared and Raman imaging. Fourier-transform infrared (FTIR) and Raman imaging was performed on native snap-frozen brain tissue sections from AD cases and non-demented control cases. Subsequently, the scanned tissue was stained against Aβ and annotated for the different plaque types by an AD neuropathology expert. In total, 160 plaques (68 diffuse, 32 compact, and 60 classic cored plaques) were imaged with FTIR and the results of selected plaques were verified with Raman imaging. In diffuse plaques, we detect evidence of short antiparallel β-sheets, suggesting the presence of Aβ oligomers. Aβ fibrillation significantly increases alongside the proposed plaque development sequence. In classic cored plaques, we spatially resolve cores containing predominantly large parallel β-sheets, indicating Aβ fibrils. Combining label-free vibrational imaging and immunohistochemistry on brain tissue samples of AD and non-demented cases provides novel insight into the spatial distribution of the Aβ conformations in different plaque types. This way, we reconstruct the development process of Aβ plaques in human brain tissue, provide insight into Aβ fibrillation in the brain, and support the plaque development hypothesis.

Indexed as

AgedAged, 80 and overAlzheimer DiseaseAmyloid beta-PeptidesDisease ProgressionFemaleHumansMalePlaque, AmyloidSpectroscopy, Fourier Transform InfraredSpectrum Analysis, RamanAmyloid beta-PeptidesAlzheimer’s diseaseAmyloid-betaAmyloid plaqueFibrilFTIRHumanImagingInfrared, RamanMicrospectroscopyOligomer

Identifiers

PMID33308303
PMCPMC7733282
OpenAlexW3113097844

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.